Subscribe to My Feed




Tell a Friend




  • Polls

    How Is My Site? / ¿Cómo es mi sitio web?

    View Results

    Loading ... Loading ...
  • Recent Comments:

  • Pharmaceutical Issues

    « Previous Entries

    Brazil Producing Generic Version of Tamiflu

    Sunday, August 2nd, 2009

    Synopsis in English: Brazil’s Pharmaceutical Technology Institute (commonly known by its old name, Farmanguinhos), a subsidiary of the state-run public health entity Oswaldo Cruz Foundation (“Fiocruz“), has started producing capsules of oseltamivir phosphate, the generic version of the marketed by pharma multinational Roche as Tamiflu, for distribution by the Health Ministry (MS) to reference hospitals […]

    Share

    A New Initiative on Chagas / Nova iniciativa sobre Doença de Chagas

    Saturday, July 11th, 2009

    From Drugs for Neglected Diseases initiative (DNDi):
    Forgotten and with few treatment options, Chagas debilitates and kills

    100 years since Chagas disease was discovered, DNDi launches an international campaign “Wake Up. Time to Treat Chagas Disease!” with a call for better medicines and treatment of patients.

    One hundred years after the discovery of Chagas disease, 100 million people […]

    Share

    Linking the Pharmacopeias of Argentina and Brazil

    Wednesday, July 8th, 2009

    Brazil’s National Sanitary Vigilance Agency (Anvisa) today issued a regulation (Resolution RDC 37) permitting reference chemical substances certified by either the Argentine Pharmacopeia or the World Health Organization’s (WHO) International Pharmacopeia to be used for evaluating the quality of pharmaceutical raw materials (active ingredients and excipients) and medicines produced in Brazil.
    Anvisa already allowed that, where […]

    Share

    The Main Causes of Accidential Poisoning in Jamaica’s Children

    Wednesday, May 27th, 2009

    From the Ministry of Health (MOH):
    Bleach, Pharmaceuticals and Pesticides, main agents of accidental poisoning in children … Health Ministry warns parents and caregivers
    The Ministry of Health’s surveillance reports have uncovered that bleach, pharmaceuticals (medications) and pesticides are still major household health hazards accounting for majority of cases of accidental poisoning in children.
    According to the 2008 […]

    Share

    Culmina armonización andina de requisitos para productos de higiene doméstica y absorbentes de higiene personal

    Monday, April 20th, 2009

    Synopsis in English: The Andean Community (CAN) is putting the finishing touches on the new Community norm to harmonize member states’ (Bolivia, Colombia, Ecuador, Peru) sanitary control regimes regarding household and personal hygiene products, such as soaps, detergents, fabric softeners, surface cleansers, stain removers, bleaches, air fresheners, sanitary towels, disposable diapers, tampons, towelettes, etc.
    To refresh […]

    Share

    New Pharmaceutical Labeling Rules Proposed in Brazil

    Friday, April 10th, 2009

    Brazil’s National Sanitary Vigilance Agency (ANVISA) is proposing changes in package labeling rules for pharmaceuticals sold in that country (as set out in ANVISA Resolution RDC 333/03) with a view to making pack labels more informative to consumers.  For example, the proposals released for public consultation (until 11 May) would make medicines with a sedative […]

    Share

    An Andean Medicines Policy

    Sunday, March 29th, 2009

    Last Friday the 30th Meeting of the Health Ministers of the Andean Area (RMSAA) agreed on other important health measures — a coordinated epidemiological surveillance system, joint plans to combat HIV/AIDS, protect health in border areas and to combat child malnutrition — but the one that caught my eye was the new Andean Medicines Policy.
    Not […]

    Share

    Important LAC Developments on Clinical Trials

    Monday, March 23rd, 2009

    Argentina and Brazil are creating national registries for clinical trials. Clinical trials are research studies that prospectively assign human participants or groups of humans to one or more health-related interventions (pharmaceuticals, vaccines, surgical procedures, radiological procedures, medical devices, etc.) to evaluate the effects on health outcomes, often undertaken with a view to seeking regulatory approval. […]

    Share

    Colombia Imposes Take-Back for Expired Medicines

    Monday, March 2nd, 2009

    Two years ago Environment Minister got the attention of industry when he published for public comment two draft decrees imposing extended producer responsibility (EPR) for end-of-life batteries and medicines.
    Now, after nearly two years of discussions between the Environment Ministry (MAVDT) and industry groups representing the pharmaceutical sector in Colombia — namely the Colombian Pharmaceutical Industry […]

    Share

    A Call for Scaled-Up R&D for Neglected Diseases / Una llamada para más I+D para las enfermedades olvidadas / Uma chamada para aumento de P&D sobre as doenças negligenciadas

    Monday, February 23rd, 2009

    From the Drugs for Neglected Diseases initiative (DNDi):
    MSF and DNDi Call for Scale-Up of R&D for Neglected Diseases

    Greater Governmental Leadership is needed to Foster Medical Innovation for Millions Suffering from Neglected Diseases

    The international medical humanitarian organization Médecins Sans Frontières (MSF) and the Drugs for Neglected Diseases initiative (DNDi) called today for more sustainable funding […]

    Share
    « Previous Entries